Scopus Biopharma Inc (SCPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,862 | -9,811 | -8,651 | -626 | -2,690 |
| Depreciation Amortization | 1 | 291 | 66 | 6 | 1 |
| Other Working Capital | 1,149 | 1,367 | 1,174 | 433 | 355 |
| Other Operating Activity | 7,187 | 6,547 | 6,467 | 60 | 214 |
| Operating Cash Flow | $-2,525 | $-1,606 | $-945 | $-127 | $-2,120 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -4 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-4 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,189 | 1,459 | 1,231 | 130 | N/A |
| Common Stock Issued | 3,274 | 841 | 618 | 2 | N/A |
| Other Financing Activity | -1,110 | -309 | -189 | -51 | 2,184 |
| Financing Cash Flow | $4,353 | $1,992 | $1,660 | $81 | $2,184 |
| Exchange Rate Effect | -32 | -2 | 2 | 14 | -24 |
| Beginning Cash Position | 37 | 37 | 37 | 37 | 2 |
| End Cash Position | 1,832 | 421 | 753 | 5 | 37 |
| Net Cash Flow | $1,795 | $384 | $717 | $-32 | $35 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,525 | -1,606 | -945 | -127 | -2,120 |
| Free Cash Flow | -2,525 | -1,606 | -945 | -127 | -2,120 |